- Lobbying
- Michael AND Werner
Lobbying Arrangements Results for 'Michael Werner'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Follow-on biologics/biosimilars Newborn screening Drug safety Orphan drug incentives |
Shire Human Genetic Therapies
pharmaceutical manufacturer |
THE WERNER GROUP | |||
Details HR 1548 Pathway for Biosimilars Act -- focus on orphan drug issues HR 1427 Promoting Innovation and Access to Life Saving Medicine Act -- focus on orphan drug issues |
Shire Pharmaceuticals
|
THE WERNER GROUP | |||
Details Administrative and programmatic changes to the Combined Federal Campaign; "Solicitation of Federal Civilian and Uniformed Service Personnel for Contributions to Private Voluntary Organizations -- E... |
Community Health Charities
A federation of organizations to promote and increase workplace charitable giving |
THE WERNER GROUP | |||
Details HR 873, S 487 The Stem Cell Research Enhacement Act of 2009 HR 872, The Stem Cell Research Improvement Act of 2009 |
Biotechnology Industry Organization
|
THE WERNER GROUP | |||
Details S 1932, HR 4241 Deficit Reduction Act of 2005 (Reconciliation) -- extend Medicare cost contract program S 1403, HR 4050 Medicare Cost Contract Extension and Refinement Act of 2005 -- extend/modify ... |
UCare Minnesota
Health plan/insurer |
THE WERNER GROUP | |||
Details Monitoring of the reauthorization of the Farm Bill. |
Nalu Bio, Inc.
|
HOLLAND & KNIGHT LLP | |||
Details H.R. 5298, Modernizing Drug Enforcement Act of 2018. |
Kratom Trade Association
|
HOLLAND & KNIGHT LLP | |||
Details FY 2023 Commerce, Justice, Science and Related Agencies appropriations. |
Standards Coordinating Body for Regenerative Medicine
|
Holland & Knight, LLP | |||
Details Implementation of Drug Quality & Security Act, P.L. 113-54. |
Arrow International, Inc.
|
HOLLAND & KNIGHT LLP | |||
Details Raise awareness of company's product with Department of Defense, Veterans Administration and Indian Health Service regarding its health and economic benefit versus competitor products. |
Endo Pharmaceuticals, Inc.
|
HOLLAND & KNIGHT LLP | |||
Details Advocacy regarding test coverage. |
Scipher Medicine Corporation
|
HOLLAND & KNIGHT LLP | |||
Details Advocate regarding provisions of patent reform legislation: S.1720, Patent Transparency & Improvement Act; S.1013, Patent Abuse Reduction Act. |
Actavis, Inc.
|
HOLLAND & KNIGHT LLP | |||
Details Legislation around artificial intelligence health care. |
Adjuvant Global Advisers, LLC
|
HOLLAND & KNIGHT LLP | |||
Details Medicare coverage of wound care therapies. |
Triad Life Sciences, Inc.
|
HOLLAND & KNIGHT LLP | |||
Details Manufacturing issues; Implementation of the Agriculture Improvement Act of 2018. |
Deutsche Process
|
Holland & Knight, LLP | |||
Details Lobbied for provisions to provide payment incentives for Medicare Advantage plans. Lobbied for removal of excise tax on insurers. Both provisions in HR 3590, Patient Protection and Affordable Car... |
ALLIANCE FOR COMMUNITY HEALTH PLANS
|
HOLLAND & KNIGHT LLP | |||
Details Federal funding to further development of test kits to diagnose SARS-CoV-2. |
Blandford Biotech Corporation
|
HOLLAND & KNIGHT LLP | |||
Details Medicare and Medicaid coverage of allergy testing. |
Phadia US Inc.
|
HOLLAND & KNIGHT LLP | |||
Details Federal funding regarding vaccine education. |
Essence Consulting, Inc. d/b/a Essence Patient Solutions
|
HOLLAND & KNIGHT LLP | |||
Details Support for S. 723 & H.R. 1458, Access to Prescription Digital Therapeutics Act of 2023: legislation to create CMS reimbursement category for prescription digital therapeutics. |
Bluebird Strategies
|
HOLLAND & KNIGHT LLP | |||
Details Advocated for statement of congressional intent regarding Drug Quality and Security Act. |
Safecor Health, LLC
|
HOLLAND & KNIGHT LLP | |||
Details Legislation and regulations governing oversight of genetic tests. Discussed proposed intellectual property legislation governing gene patents. Prepared advocacy materials Legislation and regulatio... |
Foundation Medicine, Inc.
|
HOLLAND & KNIGHT LLP | |||
Details Appropriations related to health care |
MED-IQ
|
HOLLAND & KNIGHT LLP | |||
Details Health information technology policy. |
Northrup Grumman Systems Corporation
|
HOLLAND & KNIGHT LLP | |||
Details COVID response; artificial intelligence policy. |
Vibrent Health
|
HOLLAND & KNIGHT LLP | |||
Details Prepare application for tax credit/grant available under Sec. 48Dof IRS code. Contacted US FDA & IRS on behalf of the client tax credit application. Determined the status of application. |
CELL THERAPEUTICS, INC.
|
HOLLAND & KNIGHT LLP | |||
Details Pending clinical issues before the FDA; COVID-19 pandemic related issues before Congress and the Development Finance Corporation. |
Noveome Biotherapeutics
|
HOLLAND & KNIGHT LLP | |||
Details FDA and EPA issues related to regulation of surgical masks. |
Ascend Performance Materials
|
HOLLAND & KNIGHT LLP | |||
Details Federal CARES Act funding. |
Aya Healthcare
|
HOLLAND & KNIGHT LLP | |||
Details Funding for research on psychedelic drugs. |
COMPASS Pathways plc
|
HOLLAND & KNIGHT LLP | |||
Details Global supply chain issues; National Defense Authorization Act; Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133). |
Teva Pharmaceuticals USA, Inc.
|
Holland & Knight, LLP | |||
Details E-mobility and lithium-ion battery safety, cyber security for medical devices and US Cyber Trust Mark, clean energy, data privacy, PFAS, Embedded carbon, and Plastics. |
UL LLC d/b/a UL Solutions
|
HOLLAND & KNIGHT LLP | |||
Details Issues related to supporting use of digital technologies to improve health equity and reduce healthcare disparities; CONNECT for Health Act of 2023 (S.2016/H.R. 4189); Access to Prescription Digita... |
Digital Health for Equitable Health Alliance
|
HOLLAND & KNIGHT LLP | |||
Details Raising awareness about company's product pipeline; FDA regulation of dietary supplements. |
Johnson Foods, LLC
|
HOLLAND & KNIGHT LLP | |||
Details Medicare and Medicaid coverage for allergy testing; CMS guidance change in allergy testing. |
Thermo Fisher Scientific, Inc.
|
HOLLAND & KNIGHT LLP | |||
Details Ongoing engagement to extend emergency state staffing flexibility (unemployment insurance programs); engage agencies to seek waiver request for state UI staffing extension; other Dept of Labor outr... |
Capitol Bridge, LLC
|
HOLLAND & KNIGHT LLP | |||
Details FDA regulation regarding nutrition claims. |
Ekaterra Tea MSO USA, LLC dba Lipton Teas & Infusions
|
HOLLAND & KNIGHT LLP | |||
Details Gather ideas/perfom research for development of synthetic biology legislation. Met with congressional staff to discuss proposed legislation to support synthetic biology research and biosecurity. |
LIFE TECHNOLOGIES CORPORATION
|
HOLLAND & KNIGHT LLP | |||
Details Regulation of the pharmaceutical supply chain and creation of federal licensure for third party logistics providers; Drug Quality and Security Act; Device Distribution Licensing Act. |
UPS
|
HOLLAND & KNIGHT LLP | |||
Details Pension reform legislation. ERISA issues and IRS guidance on retirement plan rollovers. |
BENETRENDS, INC.
|
HOLLAND & KNIGHT LLP | |||
Details FDA product approval. |
CleanWell, LLC
|
HOLLAND & KNIGHT LLP | |||
Details Issues related to Medicare coverage and payment of Durable Medical Equipment. |
Pride Mobility Products Corporation
|
HOLLAND & KNIGHT LLP | |||
Details Increasing Transparency in Generic Drug Applications Act, (S. 775), Part D Formulary Design; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; ... |
Viatris, Inc.
|
HOLLAND & KNIGHT LLP | |||
Details Work to secure funding in Department of Defense Appropriations bill for FY 2011 to fund research regarding treatment for spinal cord injury; Get congressional support for company's application for ... |
Q THERAPEUTICS, INC.
|
HOLLAND & KNIGHT LLP | |||
Details Vaccine dissemination and distribution; pandemic vaccine and testing policies; funding for COVID testing; pharmacy benefit manager policies and oversight; S.127 - Pharmacy Benefit Manager Transpare... |
Nomi Health
|
HOLLAND & KNIGHT LLP | |||
Details Educating members of Congress on cannabis marketplace; the SAFE Act and related federal legislation and regulation. |
Eaze Solutions, Inc.
|
HOLLAND & KNIGHT LLP | |||
Details IPPS provisions related to Medicare organ procurement costs; H.R. 4362 - Saving Organs One Flight at a Time Act; requesting guidance on decertification. |
Association of Organ Procurement Organizations
|
HOLLAND & KNIGHT LLP | |||
Details Policies related to labeling in the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations legislation; chronic pain surveillance legislation; Advancing R... |
Protecting Access to Pain Relief Coalition
|
HOLLAND & KNIGHT LLP | |||
Details Support increased funding for cancer-related federal programs. Funding for cancer-related health services. |
American Cancer Society Cancer Action Network
|
HOLLAND & KNIGHT LLP | |||
Details H.R. 3557, the American Broadband Act of 2023 S. 340 The Protecting Community Television Act of 2023 H.R. 3557, the American Broadband Act of 2023 H.R. 907 The Protecting Community Television Act o... |
National Association of Telecommunications Officers and Advisors
|
in-house lobbying |